Home > Food & Beverages > Proteins > Animal-Based Proteins > Human Milk Oligosaccharides (HMO) Market

Human Milk Oligosaccharides (HMO) Market Share

  • Report ID: GMI6413
  • Published Date: Aug 2023
  • Report Format: PDF

Human Milk Oligosaccharides Market Share

Some of the major companies operating in the human milk oligosaccharides market are:

  • DuPont Nutrition & Biosciences
  •  Jennewein Biotechnologie GmbH
  •  Glycom A/S
  •  Inbiose NV
  •  BASF SE
  •  Nestlé S.A
  •  Abbott Laboratories
  •  Glycosyn LLC
  •  ZuChem Inc
  • Tereos Starch & Sweeteners
  •  Jenica Research Corporation
  •  Novalac
  •  GlycoUniverse GmbH
  •  Biostime International Holdings Limited
  •  Clasado Biosciences.

These companies focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these companies are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of human milk oligosaccharides reached USD 200 million in 2022 and is estimated to cross USD 1518.8 million by the end of 2032.

Neutral HMO accounted for a market value of USD 122 million in 2022 as the product is known for its anti-adhesive properties, which means it can prevent pathogens from adhering to the intestinal lining.

The U.S. market held over USD 62.72 million revenue in 2022, as the consumers are increasingly focused on health and wellness, seeking products that offer functional benefits.

Glycosyn LLC, ZuChem Inc, Tereos Starch & Sweeteners, Jenica Research Corporation, Novalac, GlycoUniverse GmbH, Biostime International Holdings Limited, Clasado Biosciences.

Human Milk Oligosaccharides Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 137
  • Countries covered: 21
  • Pages: 120
 Download Free Sample